書籍詳細

I. 妊娠中毒症の成因・病態の最近の考え方

P.7 掲載の参考文献

• 1) Walsh SW:Physiology of low dose aspirin therapy for the prevention of preeclampsia. Seminars in perinatology, 14:152-170, 1990.
  pubmed

• 2) Woods LL:Importance of prostaglandins in hypertension during reduced utero placental perfusion pressure. Am Physiol Society, R1558-R1561, 1989.

• 3) Combs CA:Experimental preeclampsia produced by chronic constriction of the lower aorta; Validation with longitudinal blood pressure measurements in conscious Rhesus Monkeys. Am J Obstet Gynecol, 169:215-223, 1993.
  pubmed

• 4) Tranquilli AL:Normotensive women with intrauterine growth retardation showincreased diastolic MESOR in automated blood pressure monitoring. Am J Obstet Gynecol, 168:319, 1993.

• 5) Leiberman JR:The association between increased mean arterial pressure and abnormal uterine artery resistance to blood flow during pregnancy. Obstet Gynecol, 82:965-969, 1993.
  pubmed

P.15 掲載の参考文献

• 1) Speroff L:Physiologic and pharmacologic roles for prostaglandins in obstetrics. Clin Obstet Gynecol, 16:109-129, 1973.
  pubmed

• 2) Demers LM, Gabbe SG:Placental prostaglandin levels in preeclampsia. Am J Obstet Gynecol, 126:137-139, 1976.
  pubmed

• 3) Keirse MJNC, Erwich JJHM, Klok G:Not prostacyclin synthetase but prostaglandin erldoperoxide synthetase increase with human placental development. Prostaglandins, 31:527-534, 1986.

• 4) Keirse MJNC, Moonen P, Klok G:Control of prostacyclin synthesis in pregnancy-induced hypertension. Prostaglandins, 29:643-650, 1985.

• 5) 関 博之, 神保利春, 佐藤和雄:妊娠中毒症血管内皮細胞のphospholipase A2活性. 血液と脈管, 18:582-588, 1987.

• 6) 関 博之, 三橋直樹, 水野正彦, 佐藤和雄:妊娠中毒症の病態形成におけるPGI2合成系の酵素活性の意義. 日産婦誌, 42:1189-1194, 1990.

• 7) 関 博之, 水野正彦, 佐藤和雄, 中林正雄:妊娠中毒症の母体, 胎児血管系におけるPGI2産生能の酵素学的考察. 日産婦誌, 39:905-910, 1987.

• 8) 関 博之, 佐藤和雄:降圧因子系を中心として. 友田 豊 佐藤和雄編, 妊娠時の血圧調節機構と病態生理, p60-70, 日本アクセル・シュプリンガー社, 1989.

• 9) 関 博之, 石原 理, 竹田 省, 木下勝之, 坂元正一:妊娠中毒症とプロスタグランジン. 妊娠中毒症-最近の動向, p177-184, 江口勝人編集, 金原出版, 1992.

• 10) Barton JR, Sibai BM:Low-dose aspirin to improve perinatal outcome. Clin Obstet Gynecol, 34:251-261, 1991.
  pubmed

• 11) Italian Study of Aspirin in Pregnancy:Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet, 341:396-400, 1993.
  pubmed

P.27 掲載の参考文献

• 1) Wegmann TG & Gill III TJ, eds:Immunology of Reproduction. Oxford University press, Oxford, UK, 1983.

• 2) Andreanii D, Bompiani G, DiMario U, Faulk WP and Galluzzo A, eds:Immunology of Normal and Diabetic pregnancy, Willy and Sons, Chichester, UK, 1990.

• 3) Redman CWG, et al:Immunological dosorders of human pregnancy. Oxford Rev Reprod Biol, 8:223, 1986.

• 4) Gleicher N:Pregnancy and autoimmunity. Acta Haematol, 76:68, 1986.
  pubmed

• 5) De la Torre, et al:Prevalence of antinuclear antibodies in patients with habitual abortion and in normal and toxemic pregnancies. Rheumatol Int, 4:87, 1984.

• 6) 山本樹生, 他:妊娠中毒症における抗ラミニン抗体の検索. 日本臨床免疫学会雑誌, 14:9, 1991.

• 7) 稲葉憲之:自己免疫抗体および血清補体値による妊娠中毒症の発症予知. 産と婦, 11:2019, 1978.

• 8) Parke A, et al:Subclinical autoimmune diseases and recurrent spontaneous abortion. J Rheumatol, 13:1178, 1986.
  pubmed

• 9) Klonoff-Cohen HS, et al:An epidemiologic study of contraception and preeclampsia. JAMA, 262:3143, 1989.
  pubmed

• 10) MacQuarrie I:Apossible relationships between interaggultination and the toxemia ofpregnancy. Johns Hopkins Hosp Bull, 34:51, 1983.

• 11) Scott JR, et al:Immunologenic factors in preeclampsia and eclampsia, Erythrocyte histocomps fibility and Y-dependent antigens. JAMA, 235:402, 1979.

• 12) Tovianen P, et al:Sex ratios of newbornes; Preponderance of males in toxemia of pregnancy. Science, 170:187, 1974.

• 13) 大野 乾:精巣の分化とHY抗原. 新生理学大系, 21巻, p.29, 医学書院, 1989.

• 14) Kaku M:Placental polysaccarides and aetiology of toxaemia of pregnancy. J Obstet Gynecol Br Commonwelth, 60:149, 1953.

• 15) Levanon Y, Rossetini SMO:Presence of circulating placental antigens and antibodies in toxemia and normal pregnancy patients. Zeit Immunitas, 178:186, 1968.

• 16) Gaugas JM, et al:Complement fixing antibody against solubilized placental microsomal fraction in preeclampsia sera. Br J Pathol, 55:570, 1974.

• 17) Horne CHW, et al:Serum alpha 2 microglobulin, transfferin and IgG levels in preeclampsia. J Clin Pathol, 23:514, 1970.

• 18) Rote NS:Platelet binding immunoglobulins in pregnancy induced hypertention. Origin of circulating IgG, IgM, antiplatelet antibodies in the umblical cord serum. J Reproductive immunology, 10:273, 1987.

• 19) Ceretti N, et al:Association of anti HLA antibodies with toxemia in pregnancy, Immunology of Obstetrics and gynaecology (ed. A Cento). Excepta Medica, Holland, p231, 1974.

• 20) Harris RE and Lordon RE:The association of maternal lymphocytotoxic antibodies with obsteric complications. Obstet Gynecol, 48:302, 1976.

• 21) Jenkins DM, et al:Dificiency of specific HLA antibodies in severe pregnancy preeclampsia/eclampsia. Clin Exp Immunol, 27:485, 1977.

• 22) Thiry L, et al:Expression of retrovirus related antigens in pregnancy, cytotoxic and blocking specificities of immunoglobulins eluted from Placenta. J Reprod Immunol, 2:323, 1981.
  pubmed

• 23) Alanen A:Sperm IgG and smooth muscle antibodies in pre-eclampsia. Acta Obstet Gynecol Scand, 63:581, 1984.

• 24) Nicola M, et al:Subclinical autoimmunity in EPH gestosis. Proc VII world congress of hypertension in pregnancy, p279, 1990.

• 25) Yamamoto T, et al:Anti-ssDNA and anti-dsDNA antibodies in preeclampsia. Proc Jpn Soc Reprod Immunol, p5, 1990.

• 26) 山本樹生, 他:妊娠中毒症における抗ラミニン抗体の検索. 日本臨床免疫学会雑誌, 14:9, 1991.

• 27) Yamamoto T, et al:Measurement of antiphospholipid antibody by ELISA using purified β2 glycoprotein I in preeclampsia. Clin Exp Immunol, 94:196-200, 1993.

• 28) Rappaport VJ, et al:Anti Vascular endothelial antibodies in severe preeclampsia. Am J Obstet Gynecol, 162:138, 1990.
  pubmed

• 29) Knox GE, et al:A search for antigen antibody complex in preeclampsia, further evidence against immunologic pathogenesis. Am J Obstet Gynecol, 132:87, 1978,
  pubmed

• 30) Gleicher N, et al:Immune complexes in pregnancy. Lancet, 1:1108, 1978.

• 31) Balash J, et al:Further evidence against preeclampsia as an immune complexes diseases, Obstet Gynecol, 58:435, 1981.

• 32) Massson PL, et al:Circulation immune complexes in normal human pregnancy. Nature, 266:542, 1977.

• 33) Stirrat GM, et al:Circulating immune complexes in preeclampsia. Br Med J, 1:1450, 1978.
  pubmed

• 34) Schena FP, et al:Behaviour of immune complexes and the complement system in normal pregnancy and in preeclampsia. J Clin Exp Immunol, 7:21, 1982.

• 35) Stimson WH, et al:An assay for antigen-antibody complexes in human sera using C1q enzyme conjugate. J Clin Lab Immunol, 5:129, 1981.
  pubmed

• 36) Vasquez-Escobosa C, et al:Circulating immune complexes in hypertensive diseases of pregnancy. Obstet Gynecol, 62:45-48, 1985.

• 37) Alanen A, et al:Circulating immune complexes in hypertensive disorders of pregnancy. J Reprod Immunol, 6:133, 1984.
  pubmed

• 38) Massobrio M, et al:Immune complexes in preeclampsia and normal pregnancy. Am J Obstet Gynecol, 152:578, 1985.
  pubmed

• 39) 山本樹牛:正常妊娠および中毒症における免疫複合体と好中球機能に関する研究. 日大医誌, 40:949, 1981.

• 40) 倉本雅規:妊婦血清中における免疫複合体の役割. 日産婦誌, 34:285, 1981.

• 41) D'Amelio E, et al:Circulating immune complexes in normal pregnant women and in some conditions complicating pregnancy. Clin Exp Immunol, 37:33, 1979.

• 42) Woodroffe AJ, et al:Serum immune complexes and disease. Aust NewZealand J Med, 9:129, 1979.

• 43) 斉藤 滋:妊娠中毒症における血中免疫複合体および補体系の変動. 産婦世界, 36夏期増刊:108, 1984.

• 44) Petrucco OM, et al:Immunofluorescent studies in renal biopsies in preeclampsia. Br Med J, 1:473, 1974.
  pubmed

• 45) Tribe C, et al:A renal biopsy study in toxemia of pregnancy. J Clin Pathol, 32:681, 1979.
  pubmed

• 46) Howert-de-Jong MH, et al:Immune complexes in skin of patients with preeclamptic toxemia. Lancet, II:387, 1982.

• 47) Prall RH and Kanter FS:Serum complement in eclamptic toxemia. Am J Obstet Gynecol, 95:530, 1966.

• 48) Tedder RS, et al:Effects on serum complements of normal and preeclampsia, pregnancy and oral contraceptives. Ge J Exp Pathol, 56:389, 1975.

• 49) Fadal HE, et al:Serum complement activity in preeclamptic pregnancies. Int J Gynecol Obstet, 12:6, 1974.

• 50) Thompson NC, et al:Immunological studies in preeclamptic toxemia. Br Med J, 1:1307, 1978.

• 51) Mak LW:The complement profile in relation to the reactor state, a study in the immediate postpartum period. Clin Exp Immunol, 31:419, 1978.

• 52) 東 政弦,:晩期妊娠中毒症の本態に関する免疫学的-特に補体学的研究. 日産婦誌, 22:1127, 1970.

• 53) 山本樹生, 他:妊娠中毒症における免疫複合体と好中球機能. 産と婦, 34:285, 1982.

• 54) Gastineau D, et al:Lupus anticoagulant an analysis of the clinical and laboratory features of 319 cases. Am J haematology, 19:265, 1985

• 55) Howerd MA:Lupus anticoagulaht in women with multiple spontaneous miscarriage. Am J Haematol, 76:68, 1987.

• 56) Bransh DW:Immunological disease and fetal death. Clin Obstet Gynecol, 30:295, 1987.

• 57) Bransh DW:The association of antiphospholipid antibodies and severe preeclampsia. Obstet Gynecol, 73:541, 1989.

• 58) Walters J, et al:Anticardiolipin antibodies are associated with severe early onset preeclampsia and postpartum mobility including HELLP syndrome. Proc VII world congress of hypertension in pregnancy. p247, 1990.

• 59) Todar V, et al:Cellular hyperreactivity to placenta in toxemia of pregnancy. Eur J Obstet Gynecol Reprod Biol, 9:979, 1979.

• 60) Halbrecht IG, et al:Mixed wife-husband leucocyte cultures in disturbed andpathological pregnancies. Israel J Med Sci, 10 : 1100, 1974.

• 61) Gille J, et al:The fetomaternal lymphocyte interaction in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol, 7:227, 1977.

• 62) Sunder-Plassmann G, et al:Increased serum activity of Interleukin-2 in patients with preeclampsia. J Autoimmunol, 2:203, 1989.
  pubmed

• 63) Jenkins DM, et al:Dificiency of specific HLA antibodies in severe preeclam-psia/eclampsia. Clin Exp Immunol, 27:485, 1977.

• 64) Redman CWG, et al:Immunological aspect of human pregnancy and its disorders. In Immunological aspects of reproduction in manmmals (ed Chriopton DB), Butterworth, Guildford, p219, 1984.

• 65) Coulam C, et al:T-lymphocyte subsets during and the menstrual cycle. Am J Reprod Immunol, 4:88-90, 1983.

• 66) Bardeguez AD, et al:Cellular immunity in preeclampsia in T-lymphocyte subpopulations during early pregnancy. Obstet Gynecol, 77:859-862, 1991.

• 67) 田矢洋一, 野田 亮, 山本 雅:がん遺伝子ハンティング. 羊土社, 1990.

• 68) 早川 智, 他:癌遺伝子. 産と婦, 56:2409-2417, 1989.
  Medical*Online

• 69) Pfeifer-Ohlssen S, et al:Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta; implication for embryonic development. Cell, 38:585-591, 1984.

• 70) Goyett M, et al:Regulated transcription of c-Kiras and c-myc during compensatory growth of rat liver. Science, 219:510-514, 1983.

• 71) Kelly K, et al:Cell specific regulation of the c-myc gene by lymphocyte mytogens and platelet derived growth factor. Cell, 35:605-619, 1983.

• 72) Boupas DT, et al:Increased expression of c-myc protooncogene in the peripheral blood lymphocytes from patients with systemic lupus erythematosus andother autoimmune diseases. Arth Rheumatol, 29:755, 1986.

• 73) Klinmann DM, et al:Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med, 163:1292, 1986.

• 74) Deguchi Y, et al:Protooncogene expression and nuclear factor specifically bound to cmyc gene in peripheral blood mononuclear cells from progressive systemic sclerosis patients as the indication of clinical activity. J Clin Lab Immunol, 26:163, 1988.

• 75) Bounpas DT, et al:c-myc oncogene expression in peripheral blood mononuclear cellsfrom patients with primary Sj6gren syndrome. Arth Rheumatol, 33:49, 1990.

• 76) Hayakawa S, et al:Increased expression of c-myc protooncogene in peripheral lymphocytes in the patients with preeclampsia. In Hypertension in pregnancy (ed Cosmi), Mondutti Editore, Milano, 1991.

• 77) 佐藤和雄, 他:妊娠中毒症と免疫. 産と婦, 53:1133-1144, 1986.

• 78) 千島史尚:リンパ球のc-myc発現とそれに及ぼす妊婦血清の影響-flow cytometry による解析. 日大医誌, 49:129, 1990.

• 79) 早川 智, 他:妊娠中毒症と細胞性免疫, HLA. 産婦世界, 45:477-483, 1993.

• 80) Hayakawa S, et al:Increased expression of c-myc protooncogene in peripheral lymphocytes in the patients with preeclampsia. In Hypertension in pregnancy (ed Cosmi), Mondutti Editore, Milano, 1991.

• 81) Griffiths GM, et al:Granzyme A and perfoln as markes for rejection in cardiac transplantation. Eur J Immunol, 21:687-692, 1991.

• 82) Lipmann ML, et al:The strong correlation of cytotoxic T lymphocyte specific serine protease gene transcripts with renal allograft rejection. Transplan-tation, 53:73-79, 1992.

• 83) De Vries, RPP:HLA and disease; from epidemiology to immunotherapy, Eur J Clin Invest, 22:1-8, 1992.

• 84) Abe A, et al:Rapid DNA typing utilizing immobilized oligonucleotide probe and a non radioactive detection system. Application to HLA-DR typing of the Japanese population. JImmunol Methods, 154:205-210, 1992.

• 85) Obata F, et al:HLA-DR gene frequencies in the Japanese population obtained by oligonucleotide genotyping. Tissue Antigens, 38:124-132, 1991.
  pubmed

• 86) Kirkpatrick DC, et al:association between susceptibility to preeclampsia within families and HLA DR4. Lancet, Nov 4:1063, 1989.

• 87) Walknowska J:Practical and theoretical implications of fetal/maternal lymphocyte transfer. Lancet, 1:1119-1122, 1969.
  pubmed

• 88) Herzenberg LA, et al:Fetal cells in the blood of pregnant women; detection and enrichment by fluorescence activated cell sorting. Proc Natl Acad Sci, USA, 1979.
  pubmed

• 89) Lo YMD, et al:Prenatal sex determination by DNA amplification from maternalperipheral blood, Lancet, 2:1363-1365, 1989.

• 90) Hayakawa S, et al:Arapid molecular diagnosis of posttransfusion GVHD polymerasechain reaction directed against Y-chroosome specific SRY gene. Transfusion, 33:413-417, 1993.

• 91) Hayakawa S, et al:Possible relationships between prevalence of fetal cellsin the maternal circulation and preeclampsia. (Submitted)

• 92) Toder V, et al:Activity of NK cells in normal pregnancy and EPH gestosis. Am J Obstet Gynecol, 145:7, 1983.
  pubmed

• 93) Alanen A and Lassila O:Dificient NK cells function in preclampsia. Obstet Gynecol, 60:631, 1982.

• 94) 山本樹生, 近藤泰正:妊娠中毒症における免疫学的考察. 妊娠中毒症の病態と管理, 同朋舎出版, 京都, p121, 1982.

• 95) Chishima F, et al:Changes in granulocyte surface markers, IgG, IgM and C3 in pregnancy and preeclampsia. Acta Wr world congress of hypertention in pregnancy. Mondutti Editore, Milano, 1992.

• 96) Nordobo L, et al:Phagocytic cell activity in preclampsia. Acta Obstet Gynecol Scand, 67:499, 1988.

• 97) 飯島 悟, 他:好中球レオロジーと妊娠中毒症. 産婦世界, 45:485-494, 1993.

• 98) 秋山邦久:妊孕現象の移植免疫学的考察-特に食細胞の動態と流血中の免疫複合体について. 日大医誌, 47:1059, 1988.

• 99) 笠倉新平:妊娠における免疫の役割. 産婦世界, 45:449-456, 1993.

• 100) Kerns M & Lala PK:Bone marrow origin of decidual cell precursers in the pseudopregnant mouse uterus. J Exp Med, 155:1537-1554, 1982.

• 101) Gambel P, Rossant J, Hunziker RD:Origin of decidual cells in murine pregnancy and pseudopregnancy. Transplantation, 39:443-444, 1985.
  pubmed

• 102) Saito S, Nishikawa K, Morii T, Narita N, Enomoto M & Ichijo M:Expression of activation antigens CD69, HLA-DR interleukin-2 receptor alpha (12Ra) and IL-2Rb on T-cells of human decidua at an early stage of pregnancy. Immunology, 75:710-712, 1992.

• 103) Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K & Ichijo M:Cytokine production by natural killer cells in the human early pregnancy desidua. International Immunology, 5:559-563, 1993.

• 104) 斉藤 滋, 他:妊娠中毒症における免疫複合体, 補体, サイトカインの意義. 産婦世界, 45:477-483, 1993.

• 105) Fox H:Pathology of Placenta. Saunders, 1981.

• 106) Scott JM, et al:Fibrinous vasculosis in the human placenta. Placenta, 4:87, 1988.

• 107) Veen F, et al:Endoarteritis obliterans of the fetal stem arteries of the human placenta, an electron microscopic study. Placenta, 3:181, 1982.

• 108) Labarerre CA:Acute atherosis, A histopathological Hall mark of immune agresion? Placenta, 9:95, 1988.

• 109) 山本樹生, 他:免疫複合体と胎盤の病理形態的変化. 産婦世界, 36:116, 1983.

• 110) 井一夫:妊娠中毒における流血中免疫複合体と胎盤の変化について. 日大医誌, 49:787, 1990.

• 111) Kitzlniller JL, et al:Immunoflorescent study of placenta bed vessels in preeclampsia of pregnancy. Am J Obstet Gynecol, 115:248, 1973.

• 112) Faulk WP, et al:Immunological studies of human placentae; complement components in preeclamptic chorionic villi. Clin Exp Immunol, 27:485, 1984.

• 113) 高木繁夫, 他:妊娠中毒症と免疫. 産婦人科MOOK37, p248, 1987.

• 114) Petrucco OM, et al:Immunofluorescent study in renal biopsies in preeclampsia. Br Med J, 1:473, 1974.
  pubmed

• 115) 藤多和義:妊娠中毒症における免疫学的検討. 日腎誌, 17:1, 1975.

• 116) Arias F, et al:Hepatic fibrinogen deposits in preeclampsia. New Engl J Med, 295:578, 1976.
  pubmed

• 117) Richard A, et al:Clinicopathological study of neuronal complications due to hypertensive disorders of pregnancy. J Neur Neurosurg Psychiatry, 51:416, 1988.

• 118) Weinstein L:Syndrome of hemolysis, elevated liver enzymes, and low platelet count; A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol, 142:159, 1982.
  pubmed

• 119) Weinstein L:Discussion of the HELLP syndrome. 51th ANN Meet Central Ass Obstet Gynecol, Corolad Springs, 1983.

• 120) Weichert W:Zur Kentnis des heufirber und eklampsie bein serum. Wien Klin Wochenshr, 10:1945, 1903.

• 121) 馬杉復三, 富岡八十一:抗臓器血清による臓器の特異性変化の本態について, とくに Nephrotoxin および Hepatotoxin による腎および肝変化について. 付. 糸球体腎炎および子瘤肝の病理発生について. 千葉医誌, 9:114, 1931.

P.42 掲載の参考文献

• 1) Roberts JM, Roberts N and Goldfien A:Clinical and Biochemical Evidence of Endothelial Cell Dysfunction in the Pregnancy Syndrome Preeclampsia. Am J Hypertens, 4:700-708, 1991.

• 2) Roberts JM:Pregnancy related hypertension. In:Creasy RK, Pesnik R, eds. Maternal fetal medicine; principles and practice. Philadelphia, WB Saunders, 1989.

• 3) Robertson WB, Khong TY, Brosens I, et al:The placental bed biopsy-review from three Europian centers. Am J Obstet Gynecol, 155:401-412, 1986.

• 4) Noda M:Ultrastructural study on changes in human umbilical arterial endothelia due to various conditions during pregnancy.

• 5) 長江裕康, 占橋信晃, 矢嶋 聰, 他:妊娠中毒症における内皮細胞障害の指標としての血中細胞外基質濃度について. 日本妊娠中毒症学会誌, No.1:1-5, 1993.

• 6) Ballegeer V, Spitz B, Kieckens L, et al:Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol, 161:432, 1989.
  pubmed

• 7) Redman CGW, Denson KWE, Beilin LJ, et al:Factor-VIII consumption in preeclampsia. Lancet, ii:1249-1252, 1977.

• 8) Furchgott RF and Zawadziki JV:Nature, 288:373-376, 1980.

• 9) Moncada S, et al:Pharmacol Rev, 43:109-142, 1991.
  pubmed

• 10) 佐久間一郎:実験医学, 9:1347-1351, 1991.

• 11) Chandrasekhar Y and Garfield RE:Inhibition of nitric oxide synthesis in rat during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol, 169:1316-1320, 1993.

• 12) Miklos M and Hertelendy F:Nw-Nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol, 166:1560-1567, 1992.

• 13) Taylor RN, Varma M, Teng NN and Roberts JM:Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J CIin Endocol Metah, 71:1675-1677, 1990.

• 14) Sakurai T, Yanagisawa M and Masaki T:Tens Pharmac Sci, 13:103-108, 1992.

• 15) 0:brien WF:The prediction of Preeclampsia. Clinical Obsterics and Gynecology, 35(2):351-364, 1992.

• 16) Jaffe EA, Nachman RL, Becker CG, et al:Culture of human umbilical endothelial cells derived from umbilical veins. J CIin Invest, 52:2745, 1973.

• 17) Branch DW, Dudley DJ, LaMarches S, et al:Sera from preeclamptic Patients Contain Factor (s) that Stimulate Prostacyclin Production by Human Endothelial Cells. Essential Fatty Acids, 45:191, 1992.

• 18) SMurota, WC Chang, Y Koshihara, I Morita, Adv:PG TX LT Res, 11:99, 1983.

• 19) Funk CD and Fitz Gerald:Eicosanoid Forming Enzyme mRNA in Human Tissue. J Biol Chem, 19:266, 1991.

• 20) HLa T and Neilson K:Human cyclooxygenase 2. Proc Nath Acad USA, 89:7384, 1992.

• 21) 森田育男:培養血管内皮細胞の病態解析への応用. 血管細胞の培養法とその応用, 現代化学増刊, 16:179, 1989.

• 22) 月森清巳, 石田 清, 永田英明, 他:血管内皮細胞のバイオロジカルヘイヴィアと妊娠中毒症の病態形成に関する研究, 日本妊娠中毒症学会誌, No. 1:6, 1993.

P.50 掲載の参考文献

• 1) McCarron DA, Yung NN, Ugoretz BA, et al:Disturbances of calcium metabolism in the spontaneously hypertensive rat. Hypertension, 3 (suppl 1):1162-1167, 1981.

• 2) Kobayashi J; Geographical relation between the chemical nature of river water and death rate from apoplexy. Bio; Okayama Univ, 11:12-21, 1957.

• 3)McCarron DA; Blood pressure and nutrient intake in the United States. Science, 224:1392-1398, 1984.
  pubmed

• 5) Belizan JM, Villar J:The relationship between calcium intake and edema-, proteinuria-, and hypertention-gestosis; an hypothesis. Am J CIin Nutr, 33:2202-2210, 1980.

• 6) Belizan JM, Villar J, Salazar A, et al:Preliminary evidence of the effect of the calcium supplementation on blood pressure in normal pregnant women. Am J Obstet Gynecol, 146:175-180, 1983.

• 7) Villar J, Belizan JM, Fischer P:Epidemiologic observations on the relationship between calcium intake and eclampsia. Int J Gynecol Obstet, 21:271-278, 1983.

• 8) 伊藤昌春, 岡村 均:カルシウムの経口投与による妊娠高血圧の治療効果. 産と婦, 57:699-703, 1990.

• 9) Cutler JA, Brittaint E:Calcium and blood pressure. An epidemiologic perspective. Am J Hypertens, 3:137s-146s, 1990.

• 10) 福岡秀興, 向井申治:Ca, Vit. D代謝の母子相関. ホと臨, 36:251-257, 1988.

• 11) Davis OK, Hawkins DS, Rubin LP, et al:Serum parathyroid hormone (PTH) in pregnant women determined by an immunoradiometric assay for intact PTH. J Clin Endocrinol Metab, 67:850-852, 1988.
  pubmed

• 12) 佐藤和雄, 本田利江:妊婦, 授乳婦のカルシウム摂取. Clinical Calcium, 2:60-65, 1992.

• 13) Steichen JJ, Tsang RC, Gratton TL, et al:Vitamin D homeostasis in the perinatal period; 1, 25-dihyroxyvitamin D in matenal, cord, and neonated blood. N Engl J Med, 302:315-319, 1980.

• 14) Michael W, Varner MD, Dwight P, et al:Calcium metabolism in the hypertensive mother, fetus, and infant. Am J Obstet Gynecol, 147:762-765, 19 83.

• 15) Richard SR, Nelson DM, Zuspan FP, et al:Calcium level in normal and hypertensive pregnant patient. Am J Obstet Gynecol, 149:168-171, 1984.

• 16) 穴炸孝言, 広田桂, 吉松 淳ほか:妊娠中毒症における低力ルシウム尿症. 日産婦誌, 44:28-32, 1992.

• 17) Taufield PA, Ales KL, Resnick LM, et al:Hypocalciuria in preeclampsia. N Engl J Med, 316:715-718, 1987.
  pubmed

• 18) Sanchez-Ramos L, Jones DC, Cullen MT:Urinary calcium as an early marker for preeclampsia. Obstet Gynecol, 77:685-688, 1991.
  pubmed

• 19) Belizan JM, Villar J, Reoke J, et al:The relationship between calcium and pregnancy-induced hypertension; Up-to-date evidence. Am J Obstet Gynecol, 158:898-902, 1988.
  pubmed

• 20) 小原範之, 山崎峰夫, 森川 肇ほか:妊娠高血圧症におけるカルシウム代謝とカルシウム調節ホルモンの分泌動態. 日内分泌誌, 62:882-896, 1986.

• 21) Frenkle Y, Barkai G, Mashiach S, et al:Hypocalciuria of preeclampsia is independent of parathyroid hormone level. Obstet Gynecol, 77:689-691, 1991.

• 22) Kisch E, Dluhy R, Williams G:Regulation of renin release by calcium and ammonium ions in normal man. J Clin Endocrinol Metab 43:1343-1350, 1976.

• 23) Kotchen IA, Maull KI, Lute R, et al:Effect of acute and chronic calcium administration on plasma renin. J Clin Invest, 54:1279-1286, 1974.

• 24) Kageyama Y, Suzuki H, Arima K, et al:Oral calcium treatment lowers blood pressure renovascular hypertensive rat by suppressing the renin-angiotensin system. Hypertension, 10:375-382, 1987.
  pubmed

• 25) Kawasaki N, Matsui K, Ito M; Effect of calcium supplementation on the vascular sensitivity to angiotensin II in oregnant women. Am J Obstet Gynecol, 153:576-582, 1985.
  pubmed

• 26) Lopez-Jaramillo P, Narvaez M, Yepez R:Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. Am J Obstet Gynecol, 156:261-262, 1987.
  pubmed

• 27) Ando K, Sato Y, Ono A:Antihypertensive effect of dietary calcium loading in angiotensin II-salt rats. Am J Physiol 261:R1070-1074, 1991.
  pubmed

• 28) Peular JD, Morgan DA, Mark AI:High calcium diet reduces blood pressure in Dahl-salt sensitive rats by neural mechanisms. Hypertension, 9 (supple III); III159-III165, 1987.

• 29) Ayachi S:Increased dietary calcium lowers blood pressure in the spontaneously hypertensive rats. Metabolism, 28:1 234-1 238, 1979.

• 30) Dipette DJ, Greilich PE, Kerr NE, et al:Systemic and regional hemodynamic effects of dietary calcium supplementation in mineralcorticoid hypertension. Hypertension, 13:77-82, 1989.

• 31) 山川 弘ほか:若年常血圧者を対象とした食塩負荷の血圧およびカルシウム代謝への影響. 第7回「高血圧とカルシウム」 カンファランス, 1991.

• 32) Hellstroem J, Birk G, Edvall CA:Hypertension in hyperparathyroidism. Br J Uro, 309:13-24, 1958.

• 33) Rosenthal FD, Roy S:Hypertension and hyperparathyroidism. Br Med J, 4:396-397, 1972.
  pubmed

• 34) Brinton GS, Jubiz W, Lagerquist LD, et al:Hypertension in primary hyperparathyroidism; The role of the renin-angiotensin system. J CIin Endocrinol Metab, 41:1025-1029, 1975.

• 35) Belizan JM, Villar J, Self S, et al:The mediating role of the parathyroid gland in the effect of low calcium intake on blood pressure in the rat. ArchLatinoam Nutr, 34:666-675, 1985.

• 36) Resnick LM:Uniformity and diversity of calcium metabolism in hypertension. A conceptual framework. Am J Med, 82 (suppl 1B):16-26, 1986.

• 37) 多久和陽:ホルモン作用の発現と細胞内カルシウム. Clin Calcium, 2:8-12, 1992.

• 38) Adelstein RS, et al:Regulation and kinetics of the actinmyosin-ATP interaction. Ann Rev Biochem, 49:921-956, 1980.

• 39) 並河徹:血管平滑筋細胞におけるCa2+ 代謝. 血管, 8:105-109, 1985.

• 40) 望月眞人, 森川 肇ほか:妊娠中毒症の発生要因. 産婦治療, 53:19-24, 1986.

• 41) Villar J, Belizan JM, Repke J:The effect of calcium intake on the blood pressure of young healthy individuals. Ann NY Acad Sci, 435:509-516, 1985.

• 42) Villar J, Repke J, Belizan JM:Calcium supplementation reduces blood pressure during Pregnancy; Results of a randomized controlled clinical trial. Obstet Gynecol, 70:317-322, 1987.
  pubmed

• 4}Witteman JC:Aprospective study of nutritional factors and hypertension among US women. Circulation, 80:1320-1327, 1989,

• 43 belizan JM, Villar J, Gonzalez I, et al:Calcium supplementation to preven thypertensive disorders of pregnancy. N Engl J Med, 325:139. 9-140tt, 1991.

P.69 掲載の参考文献

• 1) Becquerel A, Rodier A:Untersuchungen uber die Zuzammensetzung des Blutes Enlangen, 1845.

• 2) Julia M Potler and Paul J Nestel:Am J Obst Gynec, 133:986, 1979.

• 3) 水谷敏郎:妊婦における高脂血症に関する研究. 日産婦誌, 29:988, 1977.

• 4) 吉岡 保ほか:妊婦の高脂血症の臨床的観察. 日産婦誌, 28:369-377, 1976.

• 5) Fredickson DS and Lees RS:A system for phenotyping hyperlipoproteinemia. Circulation, 31:321-327, 1965.

• 6) Fukumoto M, et al:Lipid metabolism in adipose tissue of pregnant rats. Nihon Univ J Med, 27:153-166, 1985.

• 7) 福井靖典:母児相関よりみた胎児発育に関する研究. 日産婦誌, 22:809, 1970.

• 8) 哲翁正博ほか:妊娠における血中脂質の正常値に関する検討. 産婦治療, 67:83-86, 1993.

• 9) 大越 敦ほか:妊婦のリポ蛋白および酵素活性. 産婦世界, 35 (6):583-588, 1983.

• 10) 平井真一:母児間の脂質代謝について. 日大医誌, 53:633-643, 1994.

• 11) Robert W, et al:Characterization of lipoprotein particles from the Golgi apparatus of rat liver. Journal of Lipid Research, Vol. 10, 1969.

• 12) 泉 康二:妊婦高脂血症における IDL, HDL 亜分画 (HDL2, HDL3) の代謝およびアポ蛋白, 酵素系に関する研究. 日大医誌, 45:721-728, 1986.

• 13) 中村治雄:血清脂質の異常と治療. p.32, 南山堂, 1990.

• 14) 山本徳男:LDLレセプター. 第90回日本医学会シンポジウム記録集, p.14, 1990.

• 15) 秦 哉:アポ蛋白の生合成機構と生理機能. 日本臨牀, 48:2466, 1990.
  Medical*Online

• 16) Campos H, et al:Differences in apolipoproteins and low density lipoprotein subfractions in postmenopausal women on and off estrogen therapy; Results from the framingham of spring study. Metabolism, 39:1033, 1990.

• 17) Yui Y, et al:Stabilizing factor is identical to apoprotein A-1 (Apo A-1). Anovel function of Apo A-1. JCIin Invest, 82:803, 1988.

• 18) 永川祐三ほか:動脈硬化症における血小板機能と PG. 動脈硬化, 13:831, 1985.

• 19) 小林信一:妊娠中毒症におけるアポリポ蛋白の検討. 日産婦誌, 44(2):223, 1992.

• 20) Nillila EA:High density lipoproteins in diabetes. Diabetes, 30:82, 1981.

• 21) Havel RJ, et al:Metabolic control and disease. WB Saunders, p. 393-434, 1980.

• 22) 山本 章:リポ蛋白とその役割, 血清脂質-その臨床, 基礎, 分析法. 中外医学社, 1981.

• 23) Goldstein JL and Brown MB:Atherosclerosis, 25:1257, 1977.

• 24) 飯沼博朗:妊娠中毒症妊婦におけるリポ蛋白. 産婦世界, 35:599-602, 1983.

• 25) 佐藤和雄, 古屋清英:血中脂質の移送. 産婦世界, 45:103-110, 1993.

• 26) Zeek and Assali:Am J CIin Path, 20:1099, 1950.

• 27) 飯沼博朗:妊娠中毒症の病態と管理. p.69, 同朋舎, 1982.

• 28) 佐藤和雄, 占屋清英:高脂血症と血栓線溶系. 日産婦誌, 45:N231-234, 1993.

• 29) 坂元正:ほか:産婦人科と栄養. 図説臨床産婦人科講座, 第26巻, p.76-77, メジカルヒュー社, 1979.

II. 診断および鑑別診断

P.82 掲載の参考文献

• 1) 一條元彦:妊娠中毒症問題委員会報告-妊娠中毒症のスコアリングについて. 日産婦誌, 41(3):369-375, 1989.

• 2) 妊娠中毒症の新しい考え方. 日本母性保護医協会, 1990.

• 3) Duncan SLB, Gensburg J, Bernard AG:Arteriolar distensibility in hypertensive pregnancy. Am J Obstet Gynecol, 100:222, 1986.

• 4) Hsueh WA, Luuetsche JA, Carlson EJ, et al:Changes in active and inactive renin throughout pregnancy. J Clin Endocrinol Metab, 54:1010-1014, 1982.

• 5) Chesley LC:Renin, angiotensin and aldosterone in pregnancy. Hypertensive Disorder in pregnancy, Chesley LC, Appletion Century Crofts, New York, p236, 1978.

• 6) Gant NF, Daley GL, Chand S, et al:Astudy of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest, 53:2682, 1973.

• 7) 曽我賢次:産科 婦人科における血漿プレカリクレインの生理と病理. 日産婦誌, 34:1763-1772, 1982.

• 8) 斉藤 勝, 羽田義信, 棟方 哲, 他:産科領域における尿中kallikreinの臨床的意義. 日産婦誌, 34:187-194, 1986.

• 9) Bates ER, et al:Circulation, 73; 1155, 1986.
  pubmed

• 10) 江口勝人, 光井行輝:血液稀釈障害. 産婦世界, 44:623-631, 1992.

• 11) 中村正雄, 占村泰典, 岡宮久明, 他:血液凝固線溶系の異常. 産婦世界, 44:647-655, 1992.

• 12) 三宅良明, 大西美也子, 坂田寿衛, 佐藤和雄, 大塚邦明:24HR連続血圧測定からみた妊娠中毒症病態の再評価と臨床的意義. 妊娠中毒症, p928, 金原出版, 1992.

P.90 掲載の参考文献

• 1) 占橋信晃, 辻永真志, 木村博史:妊娠中毒症の最近の考え方. 産婦の実際, 39(8):1147-1155, 1990.

• 2) 高木繁夫, 三宅良明, 坂田寿衛:妊娠中毒症 "管理指針". 臨婦産, 42(8):755-760, 1988.

• 3) 大沢源吾:妊娠中毒症の診療. 臨床と研究, 65(7):2108-2113, 1988.
  Medical*Online

• 4) 上田英雄, 他編:内科学. 朝倉書店, 東京, 1987.

P.100 掲載の参考文献

• 1) 根本則道, 桜井 勇:胎盤の病理各論. 胎盤-基礎と臨床, 高木繁夫・須川 佶・一条元彦・水野正彦編, 南江堂, 1991.

• 2) Fox H:Pathology of the placenta. In Major problems in pathology, vol 7, London, Saunders, 1978.

• 3) Silverberg SG, ed:Principles and practice of Surgical pathology. John Willey and Sons, NY, 1983.

• 4) Benington JL:Perinatal Pathology. In Major problems in pathology, vol 15, London, Saunders, 1984.

• 5) Hertig AT:Vascular pathology in hypertensive albuminuric toxemia of pregnancy. Clinics, 4:602-614, 1945.

• 6) Zeek PM and Assali NS:Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol, 20:1099-1109, 19. 50.

• 7) Labarrerre CA:Acute atherosis; ahistopathological hall mark of immune aggression? Placenta, 9:95-108, 1988.

• 8) Khong TY:Acute atherosis in pregnancies complicated by hypertension, small for gestational age infants and Diabetes mellitus. Arch Pathol Lab Med, 115:722-725, 1991.
  pubmed

• 9) Sommers SC:Uterine, placental, renal biopsies and fibrin deposits in toxemia of pregnancy. Diagnostic Gynecol Obstetrics, 4:193-205, 1982.

• 10) Dixon HG and Robertson WB:Astudy of the vessels of the placental bed in normotensive and hypertensive women. J Obstet Gynecol Br Emp, 65:803-809, 1958.

• 11) DeWolf F, Robertson WB and Brosens I:The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol, 118:164-174, 1974.

• 12) Brosens I, Robertson WB and Dixon HG:The physiological response of the vessels of the placental bed to normal pregnancy. J Path Bact, 93:569-579, 1963.

• 13) Robertson WB, Brosens I and Dixon HG:The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Path Bact, 93:581-591, 1963.

• 14) Gerretsen G, Huisjes HJ and Elema JD:Morphological changes of the spiral arteries in the placental bed in relation to preeclampsia and fetal growth retardation. Br J Obstet Gynecol, 88:876-881, 1981.

• 15) Khong TY, DeWolf F, Robertson WB and Brosens I:Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and bysmall for gestational age infants. Br J Obstet Gynecol, 93:1049-1059, 1986.

• 16) Redman CW:Immunological factors in the pathogenesis of preeclampsia. Contrib Nephrol, 25:120-127, 1981.
  pubmed

• 17) Zhou Y, Damsky CH, Chiu K, Robert JM and Fisher SJ:Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest, 91:950-960, 1993.

• 18) Pijinenborg, et al:Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br JObstet Gynecol, 98:648-655, 1991.

• 19) Hustin J, et al:Maternal vascular lesions in preeclampsia and intrauterine growth retardation; 1ight microscopy and immunofluorescence. Placenta, 4:489-498, 1983.
  pubmed

• 20) Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA and McLaughlin MK:Preeclampsia; an endothelial cell disorders. Am J Obstet Gynecol, 161:1200-1204, 1989.
  pubmed

• 21) Khong TY, Sawyer IH and Heryet R:An immunohistologic study of endothelialization of uteroplacental vessels in human pregnancy-Evidence that endothelium is focally disrupted bytrophoblast in preeclampsia. Am J Obstet Gynecol, 167:751-755, 1992.

• 22) Jaameli EKU and Koivuniemi AP and Carpen:Occurence of trophoblasts in blood of toxemic patients. Gynecologica, 160:. 315-320, 1965.

• 23) Schmol G:Uber das Schicksal embolisch verschleppter Plazentarzellen. Zbl Gynak, 29:129-137, 1905.

• 24) Roffman BY and Simons M:Syncytial trophoblastic embolism associated with placenta increata and preeclampsia. Am J Obstet Gynecol, 104:1218-1219, 1969.

• 25) Roberts JM and Redman CWG:Preeclampsia; more than pregnancy induced hypertension. Lancet, 341:1447-1451, 1993.

• 26) Fox H:Abnormalities of the fetal stem arteries in the human placenta. J Obstet Gynecol Br Cwlth, 74:734-738, 1967.

• 27) Veen F, Walkers S and Fox H:Endoarteritis obliterans of the fetal stem arteries of the human placenta; an electron microscopic study. Placenta, 3:181-190, 1982.

• 28) 今井一夫:妊娠中毒症における流血中免疫複合体と胎盤の血管変化について. 日大医誌, 49:787, 1990.

• 29) Scott JM:Fibrinous vasculosis in the human placenta. Placenta, 4:87-100, 1983.
  pubmed

• 30) Olofsson P, Laurini RN and Marsal K:Ahigh uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertensionand fetal growth retardation. Eur J Obstet Gynecol and reprod Biol, 49:161-168, 1993.

• 31) Wiggelworth JS:The Langhans layer in late pregnancy, a histological study of normal and abnormal cases. J Obstet Gynecol Br Cwlth, 69:355-365, 1962.

• 32) Fox H:The villous cytotrophoblast as an index of placental ischemia. J Obstet Gynecol Br Cwlth, 71:885-893, 1964.

• 33) Arnholdt H, Meisel F, Fandrey K and Lohrs U:Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Archiv B Cell Pathol, 60:365-372, 1991.
  pubmed

• 34) Colbern GT, Chiang MH and Main EK:Expression of the nonclassic histocompatibility antigenHLA-G by preeclamptic placenta. Am J Obstet Gynecol, 170:1244-1249, 1994.

• 35) Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R:Aclass I antigen, HLAG, expressed in human trophoblasts. Science, 248:220-223, 1990.

• 36) Jaques SM and Qureshi F:Chronic intervillitis of the placenta. Arch Pathol Lab Med, 117:1032-1035, 1993.

• 37) Russel P, Inflammatory lesions of the human placenta. III The histopathology villitis of unknown etiology. Placenta, 1:227-244, 1980.

• 38) Knox W and Fox H:Villitis of unknown etiology; its incidence and significance in placentae from a British population. Placenta, 5:395-402, 1984.
  pubmed

• 39) Labarrerre CA and Faulk P:Immunopathology of extraembryonic tissues in abnormal pregnancies. In Immunobiology of Normal and Diabetic pregnancy, ed Andreani D, et al. John Eileyand Sons, Chichester, 1990.

• 40) Rayne SC and Kraus FT:Placental thrombi and other Vascular lesions, Classification, Morphology and Clinical correlations. Path Res Pract, 189:2-17, 1993.
  pubmed

• 41) Watanabe K, Hayakawa S, Kondoh Y and Satoh K:In preparation.

• 42) Sen DK and Langley FA:Villous basement membrane thickening and fibrinoid necrosis in normal and abnormal placenta. Am J Obstet Gynecol, 118:276-281, 1974.
  pubmed

• 43) Hayakawa S, et al:Expression of RAG-1, 2genes in human decidual cells. J Immnology, (inpress)

• 44) Kerr JF and Harmon BV:Apoptosis, its significance in cancer and cancer therapy. Cancer, 73:2013-2026, 1994.
  pubmed

• 45) Hayakawa S, Watanabe K, Nemoto N, Shiraishi H, Sakurai K and Satoh K:Increased apoptosis in preeclamptic placentae. (submitted)

• 46) Hayakawa S, Watanabe K, Shiraishi H, Chishima F, Fujii KT, Satoh K, Nemoto N, and Sakurai I:Preeclamptic placentas exhibit both proliferation and increased apoptosis of villous trophoblast. Int J Surgical Pathol, (in press).

• 47) Anderson WR and McKay DG:Electron microscope study of the trophoblast in normal and toxemic placentas. Am J Obstet Gynecol, 95:1134-1148, 19, 66.

P.106 掲載の参考文献

• 1) Wisloeki GB, et al:Electron microscopy of the Human Placenta. Anat Record, 123:133, 1955.

• 2) Richart R:Studies of placental morphogenesis I. Radioautographic studies of Human placenta utilizing tritiated thymidine. Proc Soc Exp Biol Med, 106:829, 1961.
  pubmed

• 3) 奥平吉雄ほか:Syncytiotrophoblast 形成に関する電子顕微鏡的研究. J Electron Microscopy, 17(1):47, 1968.

• 4) 奥平吉雄ほか:ヒト胎盤の機能形態に関する電子顕微鏡的観察細胞, 9(6):207, 1977.

• 5) Bennington JL:Pathology of the placenta. pp.213, WB Saunders Ltd, London, 1978.

• 6) 日高淳夫ほか:妊娠中毒症. 臨婦産, 48(8):995, 1994.

• 7) 福田 透ほか:妊娠中毒症. 胎盤-基礎と臨床 (高木繁夫ほか編), pp.315, 南江堂, 1991.

• 8) 平野正子ほか:妊娠中毒症胎盤末梢絨毛の微小変化. 産婦世界, 43(1):17, 1991,

• 9) Brosens I, et al:The physiological response of the vessels of the placental bed to normal pregnancy. Path Bact, 93:569, 1967.

III. 検査-病態生理からみた検査

P.113 掲載の参考文献

• 1) 佐藤和雄, 三宅良明:妊娠中毒症, 周産期医学 (臨時増刊号), 21:173, 1991.

• 2) 妊娠中毒症の新しい考え方, 研修ノートNo.37, 日本母性保護医協会発行, 1990.

• 3) 真木正博:妊娠中毒症とDIC. 産婦治療, 60(6):617, 1990.

P.123 掲載の参考文献

• 1) 山本樹生, 近藤泰, 高木繁夫, 他:産婦世界, 35:773-785, 1983.

• 2) Alanen A:Acta Obstet Gynecol Scand, 63:581-582, 1984.
  pubmed

• 3) Haeger M & Unander M:Obstet Gynecol, 79:19-26, 1992.

• 4) 山本樹生:膠原病. 村田雄二編, 合併症妊娠, p261, 1993.

• 5) Reed E, Beer AE, Hutcherson H, et al:JReprod Immunol, 20:115-128, 1991.
  pubmed

• 6) Bolis PF, Bianchi MM, La Fianza A, et al:Biol Res Prog, 8:42-45, 1987.

• 7) Johnson N, Moodley J & Hammond MG:Br J Obstet Gynecol, 95:877-879, 19. 88.

• 8) Kilpatrick DC, Liston WA, Jazwinska EC, et al:Tissue Antigens, 29:232-236, 1990.

• 9) Wilton AN, Cooper DW, Brennecke SP, et al:Lancet, 336:653-657, 1990.
  pubmed

• 10) Colbern DT and Main EK:39th SGI Program Abstract, p362, 1992.

• 11) Sridama V, Yang SL, Moawad A, et al:Am J Obstet Gynecol, 147:566-569, 1983.
  pubmed

• 12) Todar V, Blank M, Gleicher N, et al:Am J Obstet Gynecol, 145:7-10, 1983.

• 13) Greer IA, Haddad NG & Daws J:Br J Obstet Gynecol, 96:978-982, 1989.

• 14) Plassmann GS, Derfler K, Wagner L, et al:J Autoimmunity, 2:203-205, 1989.

• 15) 山本樹生, 森 宏之, 他:産婦世界, 45:457-465, 1993.

• 16) Yamamoto T, Yoshimura S & Arai K, et al:Jpn J Clin Immun, 15:467-474, 1992.

• 17) Yamamoto T, Yoshimura S & Mori H, et al:Clin Exp Immunol, 94:196-200, 1993.
  pubmed

P.133 掲載の参考文献

• 1) FGary Cunningham, Paul C MacDonald, Norman F Gant, Kenneth J Leveno, Larry C Gilstrap:Hypertensive disorders in pregnancy. Williams obstrics, 19th edition, 1993.

• 2) Kanayama N, Nakajima A, Maehara K, Halim A, Kajiwara Y, Isoda H, Masui T & Terao T:Magnetic Resonance Imaging Angiography in a Case of Eclampsia. Gynecol Obstet Invest, 36:56, 1993.

• 3) 阿久津二夫, 坂井文彦, 畑 隆志, 飯塚高浩, 田崎義昭:子痛および子瘤前症の症候学的, 画像診断学的検討. 臨床神経学, 32:701, 1992.

• 4) Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B & Holman BL:Hypertensive Encephalopathy. Am J Roentgenol, 159 (2):379, 1992.

• 5) Richard A, Graham D & Bullock R:Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatry, 51:416, 1988.

• 6) Sheehan HL & Lynch JB:Pathology of Toxemia in Pregnancy. London, Churchill-Livingstone, 1973.

• 7) 赤堀周一郎, 半田 充, 高知利勝, 清水禮子, 秋本若二, 本郷基弘:MRI, 脳波により経過を追跡しえた産褥子瘤の一例. 日産婦誌, 42:1575, 1990.

• 8) Coughlin WF, McMurdo SK & Reeves T:MR imaging of Postpartum Cortical Blindness. J Comput Assist Tomogr, 13:572, 1989.
  pubmed

• 9) Vandenplas O, Dive A, Dooms G & Mahieu P:Magnetic resonance evaluation of severe neurological disorders in eclampsia. Neuroradiology, 32:47, 1990.
  pubmed

• 10) Royburt M, Seidman DS, Serr DM & Mashiach S:Neurologic involvement in hypertensive disease of pregnancy. Obstet Gynecol Survey, 46:656, 1991.

• 11) Will AD, Lewis KL & Hinshaw DB:Cerebral vasoconstriction in Toxemia. Neurology, 37:1555, 1987.
  pubmed

• 12) Strandgaard S & Paulson OB:Cerebral Autoregulation. Stroke, 15:413, 1984,
  pubmed

• 13) Trommer BL, Homer D & Michael MA:Cerebral Vasospasm and Eclampsia. Stroke, 19:326, 1989.

• 14) Lewis LK, Hinshaw DB, Will AD, Hasso AN & Thompson JR:CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology, 30:59, 1988.
  pubmed

• 15) Strandgaard S:Autoregulation of cerebral circulation in hypertention. Acta Neurol Scand, 57 (suppl 66):1, 1978.

• 16) Williams K & MacLean C:Maternal middle cerebral vascular changes associated with eclampsia. Am J Obstet Gynecol, 170:407, 1994.

• 17) Pollak VE & Nettles JB:The kidney in toxemia of pregnancy; Aclinical and pathologic study based on renal biopsies. Medicine, 39:469, 1960.

• 18) Hayreh SS:Fundus lesions in malignant hypertention. Focal intraretinal periarteriolar transudates. Ophthalmology, 93:60, 19 86.

• 19) 斉藤喜博, 大本達也, 木戸口公一, 藤田富雄, 和田芳直:妊娠中毒症の網膜脈絡膜変化. 日眼会誌, 94:870, 1990.

• 20) 松井瑞夫:妊娠中毒症と妊娠誘発性高血圧症 (PIH). 図説高血圧, 糖尿病とその眼底. 金原出版, p64, 1993.

• 21) Fastenberg DM, Fetkenhour CL & Chromokos E:Choroidal vascular changes in toxemia ofpregnancy. Am J Ophthalmol, 89:362, 1980.

• 22) Seidman DS, Serr DM & Ben Rafael Z:Renal and ocular manifestations of hypertensive diseases of pregnancy. Obstet Gynecol Surv, 46:171, 1991.

IV. 妊婦管理

P.148 掲載の参考文献

• 1) MacGillivray I:Some observations on the incidence of preeclampsia. Br J Obstet Gynecol, 65:536, 1958.

• 2) Chesley LC, Sibai BM:Clinical significance of elevated mean arterial pressure in the second trimester. Am J Obstet Gynecol, 159:275-279, 1988.
  pubmed

• 3) 三宅良明, 大西美也子, 佐藤和雄, 大塚邦明:妊娠中毒症の病態と母児管理. 産婦の実際, 40(2):141-153, 1991.

• 4) 三宅良明, 大西美也子, 佐藤和雄:夜間血圧を考える-妊娠中の血圧日内変動特に妊娠中毒症における夜間高血圧とその病態について. Therapeutic Research, 13(1):1, 1992

• 5) 江口勝人, 関場 香:妊娠中毒症の発症予知に関する最近の話題. リスク因子の分析. 産婦の世界, 39:89 p1987.

• 6) Hutte R:Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol, 83:146-149, 1994.

• 7) Fitzeraldo DJ:Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension; Circulation, 75:956-963. 1987.

• 8) Lazarchik J:Predictive value of fibronectin levels in normotensive gravid women destined to become pre-eclamptic. Am J Obstet Gynecol, 154:1050, 1986.

• 9) Lockwood CJ:Increased plasma levels of ED-1+cellular fibronectin precede the clinical science of pre-eclampsia. Am J Obstet Gynecol, 162:358, 1990.

• 10) Walters BNJ; Alpha-fetoprotein elevation in proteinuric preeclampsia. Br J Obstet Gynecol, 92:341, 1985.

• 11) Baker PN, Pipkin FB, Symonds EM:Platelet angiotensin-II binding sites in hypertension in pregnancy. The Lancet, 1151, 1989.

• 12) Zemel MB, et al:Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. New Engl J Med, 323:434-438, 1990.
  pubmed

P.156 掲載の参考文献

• 1) JR Leiberman, et al:The association between increased mean arterial pressureand abnormal uterine artery resistance toblood flow during pregnancy, Obstet Gynecol. 82:965-969, 1993.

• 2) LL Woods:Importance of prostaglandins in hypertension during reduced utero-placental perfusion pressure. Am J Phisol Society, R 1558-1561, 1989.

• 3) SP Seligman, et al:The role of nitric oxide in the pathogenesis of pre-eclampsia. Am J Obstet Gynecol, 171:944-948, 1994.

• 4) LLeduc, et al:Baroreflex function in normal pregnancy, Am J Obstet Gynecol, 165:886-890, 1991.
  pubmed

• 5) KS OIah, CWG Redman, et al:Management of severe, early preeclampsia; Is conservative management justified? Eur J Obstet Gynecol Reprod Biol, 51:175, 1993.

• 6) ESchiff, SA Friedman, BM Sibai:Conservative management of severe preeclampsia remote from term. Obstet Gynecol, 84:626-630, 1994.

P.163 掲載の参考文献

• 1) 三宅良明, 大西美也子, 他:妊娠中毒症の病態と母児管理. 産婦実際, 40(2):141-153, 1991.

• 2) 三宅良明, 大西美也子, 他:妊娠中の血圧日内変動とくに妊娠中毒症における夜間高血圧とその病態について. Therapeutic Research, 13(1):16-20, 1992.

• 3) 三宅良明, 大西美也子, 他:妊娠中毒症の治療を探る-高血圧の管理. 第2回腎と妊娠研究会記録集, p37-42, 1992.

• 4) 三宅良明, 佐藤和雄, 他:妊産婦の血圧日内変動. Modern Physician, 13(8):1131-1134, 1993.

V. 胎児管理

P.171 掲載の参考文献

• 1) Vorher H:Factors influencing fetal growth. Am J Obstet Gynecol, 142:577, 1982.

• 2) Brenner WE, et al:A standard of growth for the USA. Am J Obstet Gynecol, 126:555, 1976.
  pubmed

• 3) Eskenazi B, Fenster L, Sidney S, et al:Fetal growth retardation in infants of maltiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol, 169:1112, 1993.
  pubmed

• 4) 高木耕 郎:胎内発育障害児の胎内保育限界. 日産婦誌, 48(8):808, 1993.

• 5) Roberts JM, Taylor RN, Friedman SA, et al:New developments in preeclampsia. Fetal Medicine Review, 2:125, 1990.

• 6) Wigglesworth JC:Experimental growth retardation in the fetal rat. J Pathol Bacteriol, 88:1, 1964.

• 7) Charlton V & Johengen J:Fetal intravenous nutrional supplementation ameliorates the development of embolization-induced growth retardation in sheep. Pediatr Res, 22:55, 1987.

• 8) Clapp FJ, McLaughlin MK, Larrow R, et al:The uterine haemodynamic response to repetitive unilateral vascular embolization in the pregnant ewe. Am J Obstet Gynecol, 144:309, 1982.

• 9) Creasy RK, Barret CT, DeSweit M, et al:Experimental intrauterine growth retardation in the sheep. Am J Obstet Gynecol, 112:566, 1972.

• 10) Yallampalli C & Garfield RE:Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol, 169:1316, 1993.
  pubmed

• 11) 工藤美樹, 岩下光利, 武田佳彦:IUGRの発症機転と成長因子. 臨婦産, 47(11):1291, 1993.

• 12) Price WA, Rong L, Stiles AD, et al:Changes in IGF-I and-II, IGF binding protein, and IGF receptor transcript abundance after uterine artery ligation. Pediatr Res, 32:291, 1992.
  pubmed

• 13) SARA VR & Carlson-Skwirut C:The biosynthesis and regulation of fetal insulin-like growth factors. The Endocrine Control of the Fetus, Springer-Verlag, Berlin, Heidelberg, p223, 1988.

• 14) Hadlock FP, Harrist RB, Sharman RS, et al:Estimation of fetal weight with the use of head, body, and femur mesurements a prospective study. Am J Obstet Gynecol, 151:333, 1985.

• 15) Weiner CP, Sabbagha RE, Viasrub N, et al:Ultrasonic fetal weight prediction; The role of head circumference and femur length. Obstet Gynecol, 65:812, 1985.

• 16) Shepard MJ, Richard VA, Berkowitz RL, et al:An evaluation of two equations of predicting fetal weight by ultrasound. Am J Obstet Gynecol, 142:47, 1982.

• 17) Tudehope DI:Neonatal aspects of intra-uterine growth retardation. Fetal Medicine Review, 3:73, 1991.

• 18) Wladimiroff JW, Degani S, Noordam MJ, et al:Cerebral and umbilical arterial blood flow velocity waveforms in normal and growth-retarded pregnancies. Obstet Gynecol, 69:705, 1987.
  pubmed

• 19) Veille JC & Cohen I:Middle cerebral artery blood flow in normal and growth-retarded fetuses. Am J Obstet Gynecol, 162:391, 1990.
  pubmed

• 20) Mari G & Deter RL:Middle cerebral artery flow velocity waveforms in normal and small-for-gestational age fetuses. Am J Obstet Gynecol, 166:1261, 1992.

• 21) Goldstein I, Reece A, Pilu G, et al:Cerebellar mesurements with ultrasonography in the evaluation of fetal growth and development. Am J Obstet Gynecol, 156:1065, 1987.

P.184 掲載の参考文献

• 1) 坂田寿衛, 他:胎児への刺激による NST. 周産期医学, 17:5, 1987.

• 2) Smith CV, et al:Fetal Acoustic Stimulation Testirng-A retrospective experience with the fetal acoustic stimulation test. Am J Obstet Gynecol, 153:567, 1985.
  pubmed

• 3) Smith CV, et al:Fetal acoustic stimulation testing. Am J Obstet Gynecol, 155:131, 1986.
  pubmed

• 4) Freeman RK, et al:The use of the oxytocin challenge test for antepartum clinical evaluation of uteroplacental respiratory function. Am J Obstet Gynecol, 121:481, 1975.
  pubmed

• 5) Freeman RK, et al:Aprospective multi-institutional study of antepartum fetal heart rate monitoring. Am J Obstet Gynecol, 143:771, 1982.

• 6) Keegan KA, et al:Antepartum fetal heart rate testing-IV. The nonstress test as a primary approach-. Am J Obstet Gynecol, 136:75, 1980.
  pubmed

• 7) Keegan KA, al:Antepartum fetal heart rate testing-V. The nonstress test an outpatient approach. Am J Obstet Gynecol, 136:81, 1980.

• 8) Serafani P, et al:Antepartum fetal heartrate response to sound stimulation. Am J Obstet Gynecol, 143:41, 1984,

• 9) 坂田寿衛, 他:胎児 wellbeing の臨床的評価への胎児行動応用の基礎的研究-とくに胎児行動発現様式の解離 (dissociation) について. 口産婦誌, 43:8, 1981.

• 10) 石川久直:胎児行動からみた胎児中枢神経系の発達と成熟に関する研究. 日大医学雑誌, 43:8, 1991.

• 11) 坂田寿衛, 他:NST, VASTest. 周産期医学, 23巻増号, 1993.

• 12) Druzin ML, et al:The relationship of the NST to gestational age. Am J Obstet Gynecol, 153:386, 1985.

• 13) Sorokin Y, et al:The Association between FHR patterns and fetal movement inpregnancies between 20 and 30weeks gestation. Am J Obstet Gynecol, 143:243, 1982.

• 14) 西島重信:胎児心拍モニタリングにおける問題点とVibro acoustic stimulation test (VASTest) の臨床応用に関する研究. 日本新生児学会雑誌, 25:2, 1990.

• 15) Castillo RA, et al:The preterm NST effect of gestational age and length of study. Am J Obstet Gynecol, 160:172, 1989.

• 16) 坂田寿衛, 他:FAST (Fetal Acoustic Stimulation Test) の実際と判定法. ペリネイタルケア, 7:1, 1988.

• 17) 永石匡:聴性脳幹反応よりみた中枢神経系機能の成熟に関する研究. 日大医学雑誌, 50:2, 1991.

• 18) 坂田寿衛:音振動刺激試験. 周産期医学, 19:87, 1989.

• 19) 坂田寿衛, 他:胎児振動音響刺激 (VAS) による fetal distress の実診断. 産と婦, 58:2, 1991.

P.201 掲載の参考文献

• 1) 田中俊誠ら:胎盤機能検査. 産婦治療, 62:532-538, 1991.

• 2) 矢内原巧:胎盤機能検査 E3. 周産期医学, 18:141-142, 1988.

• 3) 工藤尚文ら:胎盤機能検査 DHA-S. 周産期医学, 18:156-157, 1988.

• 4) 望月眞人ら:胎盤機能検査 hPL. 周産期医学, 18:143-149, 1988.

• 5) 望月眞人ら:胎盤機能判定とその意義. 妊娠中毒症の病態と管理, 同朋舎, p210-224, 1982.

VI. 母児予後不良因子および予後

P.211 掲載の参考文献

• 1) 細野茂春, 他:重症妊娠中毒症から出生した早産SFD児の死因分析. 新生児誌, 96:882, 1992.

• 2) Odendaal HJ, et al:Fetal and neonatal outcome in patients with severe preeclampsis before 34 weeks. South Afr Med J, 71:555, 1987.

• 3) 中林正雄, 他:妊娠中毒症, 重症度と母子長期予後. 産と婦, 60:106, 1993.
  Medical*Online

• 4) 山口規容子, 他:胎内発育障害の臨床研究, 第3報, 妊娠中毒症母体出生児の予後に関する比較検討. 新生児誌, 24:912, 1988.

• 5) Abroug F, et al:Hellp syndrome; incidence and maternal-fetal outcome, a prospective study. Int Care Med, 18:274, 1992.

• 6) 光井行輝, 他:妊娠中毒症の病態としての血液流動学的因子の解析. 妊娠中毒症, 最近の動向, 金原出版, p121, 1992.

• 7) 山口昌俊, 他:重症妊娠中毒症における子宮内胎児死亡の予測. 周産期医学, 21:297, 1991.

• 8) 佐藤和雄, 他:妊娠中毒症の長期予後. 周産期医学, 15:1671, 1985.

VII. 治療

P.217 掲載の参考文献

• 1) 日本産科婦人科学会妊娠中毒症問題委員会報告 (妊娠中毒症の薬物療法の現況). 日産婦誌, 49:769, 1990.

• 2) 日本産科婦人科学会栄養 代謝問題委員会報告 (妊娠中毒症栄養管理指針の改正について). 日産婦誌, 33:730, 1981.

• 3) 阿部信一:妊娠中毒症. 腎栄養学, 腎と透析 (増刊), 33:126, 1992.

• 4) 佐藤和雄, 三宅良明:妊娠中毒症の食事指導. 周産期医学 (増刊), 22:121, 1992.

• 5) 雨宮 章:ライフステージ別食事指導の実際-妊娠前半期 後半期. 食事指導のABC, 日本医師会雑誌 (増刊), pp244, 1991.

P.226 掲載の参考文献

• 1) Walsh SW, et al:Low dose aspirin inhibits lipid peroxides and thromboxane but not pro-stacycline in pregnant women. Am J Obstet Gynecol, 167:926-930, 1992.

• 2) Shiff E, et al:Low dose aspirin dose not influence the clinical course of women with mild pregnancy-induced hypertension. Obstet Gynecol, 76:742, 1990.

• 3) Houth JC, et al:Low dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol, 168:1083-1093, 1993.

• 4) Brown CEL, et al:Low dose aspirin-II. Relationship of angiotensin-II pressor responses, circulating eicosanoids, and pregnancy outcome. Am J Obstet Gynecol, 163:1853-1861, 1990.

P.231 掲載の参考文献

• 1) Naden RP & Redman CWG:Antihypertensive drugs in pregnancy. Clin Perinatol, 12:521-538, 1985.

• 2) Sibai BM, et al:Acomparison of no medication versus methyldopa of labetanol in chronic hypertension durings pregnancy. Am J Obstet Gynecol, 162:960-967, 1990.

• 3) 中山道男, 他:妊娠中毒症問題委員会報告 「妊娠中毒症の薬物療法の現況」 日産婦誌, 42:769-777, 1990.

• 4) Lunell NO, Lewander R, Nylund L, et al:Acute effect of dihydralazine of utero-placental blood ow in hypertension during pregnancy. Gynecol Obstet Invest, 16:274, 1983.

• 5) Walters BNJ & Redman CWG:Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. Br J Obstet Gynecol, 91:330, 1984.

• 6) 松本泰俊, 高尾篤良:循環器用剤. 清水直容, 他監修 「妊婦への投薬」, p142, ミクス出版, 1989.

• 7) 角田一男, 阿部圭志:妊娠と高血圧. 腎と透析, 35 (5):91-102, 1993.

• 8) Cotton DB, et al:Cardiovascular alterations in severe pregnancy-induced hypertension; Effects of intravenous nitroglycerin coupled with blood volume expansion. Am J Obstet Gynecol, 154:1053, 1986.
  pubmed

• 9) 山本樹生, 磯部 聡, 池田 誠, 他:ニトログリセリンを用いた重症妊娠中毒症の血圧管理. 日産婦関東連合会報, 51:11-16, 1990.

• 10) 松本隆史:高血圧, 妊娠中毒症. 村田雄二監修 「合併症妊娠」, p104, 1993.

• 11) Pinper JM, Ray WA, Rosa FW, et al:Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol, 80:429-432, 1992.

• 12) Ounsted M, Cockburm J, et al:Maternal hypertension with super-imposed preeclampsia; Effects on child development at 7 years. Br J Obstet Gynecol, 90:644, 1983.

• 13) Seab SJ, et al:Nifedipine in acute hypertensive emergencies in pregnancy. S Atr Med J, 76:248-250, 1989.

• 14) Constantine G:Nifedipine as a second line anti-hypertensive drug in pregnancy. Br J Obstet Gynecol, 94:1136-1142, 1987.

• 15) Nylund L, Lunell NO, et al:Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the utero placental blood flow. Acta Obstet Gynecol Scand, 118:71, 1984.
  pubmed

P.237 掲載の参考文献

• 1) Stenchever MA:Magnesium its relationship to obsterics. Obstet Gynecol Surve, 16:297, 1961.

• 2) Iseri LT & French JH:Magnesium; nature:s physiologic calcium blocker. Am Heart J, 108:188-193, 1984.

• 3) Lazaed EM:Preliminary report in intravenous use of magnesium sulfate in puerperal eclampsia. Am J Obstet Gynecol, 9:179, 1925.

• 4) 松本隆史, 村田雄二, 二宮有子, 他:硫酸マグネシウム (MgS04) によるPIHの治療. 産婦実際, 40(2):163-172, 1991.

• 5) Dancis J, Springer D & Cohlan SQ:Fetal homeostasis in maternal malnutriction II. Magnesium deprivation. Pediat Res, 5:131-136, 1971.

• 6) Hall DG:Serum magnesium in pregnancy. Obstet Gynecol, 9:158-162, 1957.
  pubmed

• 7) Lipsitz PJ & English IC:Hypermagnesemia in the newborn infant. Pediatrics, 40:856-862, 1967.
  pubmed

• 8) 佐藤和雄, 三宅良明, 坂田寿衛:妊娠中毒症の治療. 周産期医学, 21(1):53-56, 1991.

• 9) Safra MJ, et al:Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet, ii:478-540, 1975.
  pubmed

• 10) 中山道男, 他:妊娠中毒症問題委員会報告 (妊娠中毒症の薬物療法の現況). 日産婦誌, 42(7):769-777, 1990.

• 11) 松田清治:妊婦への投薬 「精神神経用剤」. 臨床医薬情報, 2(3):60-64, 1983.

• 12) 飯沼一宇, 他:新生児Barbiturate Withdrawal Syndrome の1例. 小児科, 20:765-768, 1982.

• 13) 前田和夫, 他:Fetal Hydantoin Syndromeの麻酔. 麻酔, 31:1260-1264, 1982.
  Medical*Online

• 14) Densky L, et al:Teratology, 33:53A, 1986.

• 15) Zuspan FP:Hypertensive Disorders of Pregnancy. Clinical Obsterics, p654, John Wiley & Sons Inc, 1987.

• 16) 日本大学医学部産科婦人科編:産科マニュアル. p56-63, 1993.

VIII. ターミネーション

P.248 掲載の参考文献

• 1) 中山道男, 他:妊娠中毒症問題委員会報告. 日産婦誌, 42:303, 1990.

• 2) 三宅良明, 他:妊娠中毒症における妊娠terminationの基準. 腎と妊娠研究会記録集, 1:81, 1992.

• 3) 日本産科婦人科学会編:日本産科婦人科学会妊娠中毒症問題委員会 (昭和60年7月会告). 産科婦人科用語解説集, 金原出版, 1988.

• 4) 古橋信晃:妊娠中毒症管理の新しいポイント. 金原出版, 1994.

• 5) Sibai BM:The HELLP syndrome (hemolysis, elevated liver enzyme, and low platelets). Am J Obstet Gynecol, 162:311, 1990.
  pubmed

• 6) 水上尚典, 他:急性妊娠脂肪肝. 臨婦産, 423:719, 1988.

• 7) Manning FA, et al:Antepartum fetal risk assessement; the role of the fetal biophysical profile score. Baill Clin Obst/Gynaec, 1:55, 1987.

• 8) Manning FA, et al:Fetal assessement based on fetal biophysical profile scoring; Experience in 19221referred high-risk pregnancies. Am J Obstet Gynecol, 157:880, 1987.
  pubmed

• 9) 金岡 毅, 他:パルスドプラー法による子宮胎盤循環動態の検索. 産と婦, 55:2009, 1988.
  Medical*Online

• 10) Gluck L, et al:Diagnosis of the respiratory distress syndrome by amnicintesis. Am J Obstet Gynecol, 109:440, 1971.
  pubmed

• 11) Spellacy WN, et al:Amniotic fluid lecithin/Sphingomyelin ratio as an index of fetal maturity. Obstet Gynecol, 39:852, 1972.
  pubmed

• 12) Clements J, et al:Assessement of the risk of the respiratory distress syndrome rapid test for surfactant in amniotic fluid. N Engl J Med, 286:1077, 1972.
  pubmed

• 13) 佐藤和雄, 他:妊娠中毒症患者の妊娠クーミネーション指針. 産と婦, 57:605, 1991.